Key facts
- Komodo Health’s last known valuation is $3.3B (Mar 2021).
- It has raised $534.5M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Andreessen Horowitz, Tiger Global Management, Coatue Management, Felicis, ICONIQ Growth — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Komodo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Komodo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Komodo Health
Developer of a healthcare technology platform intended to create a new standard for real-world data and analytics through its platform and healthcare map. The company offers a suite of software applications that deliver patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems, enabling health and life sciences enterprises to unearth insights to inform decision-making, close gaps in care, and reduce disease burden.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2014
- Employees
- 785
- Website
- komodohealth.com/
- Ownership
- Privately Held (backing)
Komodo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Komodo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Komodo Health in its N-PORT filings yet. We sweep new filings monthly.